Bullous pemphigoid is a skin disorder characterized by blisters.
Bullous pemphigoid is an autoimmune disorder that occurs when the body's immune system attacks and destroys healthy body tissue by mistake. Specifically, the immune system attacks the proteins that attach the top layer of skin (epidermis) to the bottom layer of skin.
This disorder usually occurs in older persons and is rare in young people. Symptoms come and go. The condition often goes away within 5 years.
Most people with this disorder have itchy skin that may be severe. In most cases, there are blisters, called bullae.
- Blisters are usually located on the arms, legs, or middle of the body. In rare cases, blisters can form in the mouth.
- The blisters may break open and form open sores (ulcers).
Exams and Tests
The health care provider will examine the skin and ask about the symptoms.
Tests that may be done to help diagnose this condition include:
- Blood tests
- Skin biopsy of the blister or the area next to it
Anti-inflammatory medicines called corticosteroids may be prescribed. They may be taken by mouth or applied to the skin. More powerful medicines may be used to help suppress the immune system if steroids do not work, or to allow lower steroid doses to be used.
Antibiotics in the tetracycline family may be useful. Niacin (a B complex vitamin) is sometimes given along with tetracycline.
Your provider may suggest self-care measures. These may include:
- Applying anti-itch creams to the skin
- Using mild soaps and applying moisturizer to the skin after bathing
- Protecting the affected skin from sun exposure and from injury
Bullous pemphigoid usually responds well to treatment. The medicine can often be stopped after several years. The disease sometimes returns after treatment is stopped.
Skin infection is the most common complication.
Complications resulting from treatment may also occur, especially from taking corticosteroids.
When to Contact a Medical Professional
Contact your provider if you have:
Habif TP. Vesicular and bullous diseases. In: Habif TP, ed. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 6th ed. Philadelphia, PA: Elsevier; 2016:chap 16.
PeñaS, Werth VP. Bullous pemphigoid. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulson IH, eds. Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 5th ed. Philadelphia, PA: Elsevier; 2018:chap 33.
- Last reviewed on 4/16/2019
- Michael Lehrer, MD, Clinical Associate Professor, Department of Dermatology, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2002 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.